News

ND BioSciences est la sixième entreprise à rejoindre le StartLab

La start-up qui veut combattre les maladies neurodégénératives par des traitements novateurs a été choisie pour s’installer dans l’incubateur du Biopôle des hauts de Lausanne.

Award winning ND BioSciences joins StartLab

ND BioSciences, the Swiss biotech co-founded by Prof. Hilal Lashuel, the director of the laboratory of molecular and chemical biology of neurodegeneration at EPFL’s Brain Mind Institute is the 6th venture to join Biopôle’s StartLab incubation program. The startup aims to accelerate the development of early diagnostics and therapies for neurodegenerative diseases (NDs) such as Parkinson’s or Alzheimer’s disease.

ND-BioSciences awarded a new grant from The Michael J. Fox Foundation to develop more accurate and sensitive assays for quantifying α-Synuclein

Epalinges, 26 November 2019
ND BioSciences, a Swiss-based biotechnology company that was founded with the mission of accelerating the development of early diagnostics and therapies for neurodegenerative diseases, today announced that it has received a new grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

ND-BioSciences awarded a grant from The Michael J. Fox Foundation to help advance the foundation’s α-Synuclein biomarkers discovery and validation programs

Epalinges, 1 October 2019
ND BioSciences, a Swiss-based biotechnology company that was founded with the mission of accelerating the development of early diagnostics and therapies for neurodegenerative diseases, today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a grant of for its Protein Science and Discovery program.